Literature DB >> 17356399

Acute encephalopathy and cerebral vasospasm after multiagent chemotherapy including PEG-asparaginase and intrathecal cytarabine for the treatment of acute lymphoblastic leukemia.

Catherine M Pound1, Daniel L Keene, Kristin Udjus, Peter Humphreys, Donna L Johnston.   

Abstract

A 7-year-old girl with an unusual reaction to induction chemotherapy for precursor B-cell acute lymphoblastic leukemia (ALL) is described. The patient developed acute encephalopathy evidenced by behavioral changes, aphasia, incontinence, visual hallucinations, and right-sided weakness with diffuse cerebral vasospasm on magnetic resonance angiography after the administration of intrathecal cytarabine. Vincristine, dexamethasone, and polyethylene glycol-asparaginase were also administered before the episode as part of induction therapy. Neurologic status returned to baseline within 10 days of the acute event, and magnetic resonance angiography findings returned to normal 4 months later.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17356399     DOI: 10.1097/MPH.0b013e3180335043

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  3 in total

1.  The toxicity of very prolonged courses of PEGasparaginase or Erwinia asparaginase in relation to asparaginase activity, with a special focus on dyslipidemia.

Authors:  Wing H Tong; Rob Pieters; Hester A de Groot-Kruseman; Wim C J Hop; Joachim Boos; Wim J E Tissing; Inge M van der Sluis
Journal:  Haematologica       Date:  2014-08-22       Impact factor: 9.941

2.  Comment on Ammonia level as a proxy of asparaginase inactivation in children: A strategy for classification of infusion reactions.

Authors:  Wing H Tong
Journal:  J Oncol Pharm Pract       Date:  2021-04-13       Impact factor: 1.809

3.  Reversible cerebral vasoconstriction syndrome after intrathecal cytarabine.

Authors:  Natalia Trombini Mendes; Luiza Ramos de Freitas; Rônney Pinto Lopes; Lohana Santana Almeida da Silva; Francisco Tomaz Meneses de Oliveira
Journal:  Hematol Transfus Cell Ther       Date:  2020-12-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.